Rein Therapeutics, Inc. Common Stock Shares Outstanding

Quick Answer

Rein Therapeutics, Inc. reported Common Stock Shares Outstanding of 27.55 million shares for the year ending 2025.

  • Rein Therapeutics, Inc. showed an increase of +27.2% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from Rein Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
  • XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 10 years of available data (2016 to 2025), Rein Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 6,271.3%.
  • Historical annual values: Fiscal year 2025: 27.55 million shares | Fiscal year 2024: 21.67 million shares | Fiscal year 2023: 4.89 million shares | Fiscal year 2022: 4.54 million shares | Fiscal year 2021: 4.53 million shares | Fiscal year 2020: 43.80 million shares | Fiscal year 2019: 27.81 million shares | Fiscal year 2018: 14.75 million shares | Fiscal year 2017: 14.72 million shares | Fiscal year 2016: 432,413 shares.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: